We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Anthem Extends Alliance with Inovalon, Boosts Customer Value
Read MoreHide Full Article
Leading U.S.-based Health Maintenance Organization (HMO), Anthem Inc. , recently declared a multi-year extension of its partnership with Inovalon Holdings, Inc. (INOV - Free Report) .
Anthem has been growing its membership base through accretive acquisitions. The company is presently on track to acquire Cigna Corp (CI - Free Report) . The deal is likely to help increase Anthem's size and scale and elevate its position in the industry.
Over the last three months, the Anthem stock has gained momentum. Shares of the company gained 21% compared with the 17% increase by the Zacks categorized HMO industry. The stock price appreciation is likely to have been driven by the company’s diverse product portfolio, divestitures, prudent capital management, modest cash position, strategic acquisitions and ACO arrangements.
The recent contract extension with Inovalon will boost Anthem’s commercial health insurance, Medicare and Medicaid businesses. Inovalon is a renowned technology company that provides advanced, cloud-based platforms that facilitate the data-driven transformation from volume-based to value-based models across the healthcare ecosystem. We expect Anthem to capitalize on Inovalon’s technological strength as the deal will provide the former access to the Data Diagnostics technology of the former. Data Diagnostics is a point-of-care healthcare analytics technology that Inovalon jointly designed with Quest Diagnostics, Inc. (DGX - Free Report) .
The alliance will also combine the strengths of the two companies to maximize value and impact to consumers. The partnership is likely to achieve a highly efficient, best-practices integration of data-driven, value-based technologies by applying an integrated set of Inovalon’s modular platform capabilities and Anthem’s internal capabilities.
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2017?
Who wouldn't? As of early December, the 2016 Top 10 produced 5 double-digit winners including oil and natural gas giant Pioneer Natural Resources which racked up a stellar +50% gain. The new list is painstakingly hand-picked from 4,400 companies covered by the Zacks Rank. Be among the very first to see it>>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Anthem Extends Alliance with Inovalon, Boosts Customer Value
Leading U.S.-based Health Maintenance Organization (HMO), Anthem Inc. , recently declared a multi-year extension of its partnership with Inovalon Holdings, Inc. (INOV - Free Report) .
Anthem has been growing its membership base through accretive acquisitions. The company is presently on track to acquire Cigna Corp (CI - Free Report) . The deal is likely to help increase Anthem's size and scale and elevate its position in the industry.
Over the last three months, the Anthem stock has gained momentum. Shares of the company gained 21% compared with the 17% increase by the Zacks categorized HMO industry. The stock price appreciation is likely to have been driven by the company’s diverse product portfolio, divestitures, prudent capital management, modest cash position, strategic acquisitions and ACO arrangements.
The recent contract extension with Inovalon will boost Anthem’s commercial health insurance, Medicare and Medicaid businesses. Inovalon is a renowned technology company that provides advanced, cloud-based platforms that facilitate the data-driven transformation from volume-based to value-based models across the healthcare ecosystem. We expect Anthem to capitalize on Inovalon’s technological strength as the deal will provide the former access to the Data Diagnostics technology of the former. Data Diagnostics is a point-of-care healthcare analytics technology that Inovalon jointly designed with Quest Diagnostics, Inc. (DGX - Free Report) .
The alliance will also combine the strengths of the two companies to maximize value and impact to consumers. The partnership is likely to achieve a highly efficient, best-practices integration of data-driven, value-based technologies by applying an integrated set of Inovalon’s modular platform capabilities and Anthem’s internal capabilities.
Zacks Rank and Stocks to Consider
Antem presently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.
Zacks' Top 10 Stocks for 2017
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2017?
Who wouldn't? As of early December, the 2016 Top 10 produced 5 double-digit winners including oil and natural gas giant Pioneer Natural Resources which racked up a stellar +50% gain. The new list is painstakingly hand-picked from 4,400 companies covered by the Zacks Rank. Be among the very first to see it>>